Facebook

All categories

  • All categories
  • Flow Cytometry Antibodies
  • Immunoassays
  • Antibodies and Reagents
  • Cell Identification Kits
  • Cell Isolation Products
  • Cell Health and Metabolism Assay Kits
  • Proteins and Peptides
  • Cell Culture
Please enter the item number/product keyword!
Keyword cannot be empty !
INSERT SYMBOLS:
  • α
  • β
  • γ
  • δ
  • ε
  • ζ
  • η
  • θ
  • κ
  • μ
  • ω
  • σ
  • τ
  • λ
  • ⅩⅢ
  • ⅩⅢ
  • ⅩⅣ
  • ⅩⅤ
  • ⅩⅦ
  • ⅩⅧ
  • UP ↑

Human AGER (Total Advanced Glycosylation End Product Specific Receptor) CLIA Kit (E-CL-H0241)

Human AGER (Total Advanced Glycosylation End Product Specific Receptor) CLIA Kit - 1
  • Human AGER (Total Advanced Glycosylation End Product Specific Receptor) CLIA Kit - 1
  • Human AGER (Total Advanced Glycosylation End Product Specific Receptor) CLIA Kit - 2
  • Human AGER (Total Advanced Glycosylation End Product Specific Receptor) CLIA Kit - 3
All Size Price Qty
96T $ 682.00
- +
48T $ 546.00
- +
24T $ 180.00
- +
96T*5 Inquire /
96T*10 Inquire /
Add to cart

For research use only.

Product Summary
Sensitivity 9.38 pg/mL
Detection Range 15.63-1000 pg/mL
Sample Volume 100 μL
Total Assay Time 3 h 30 min
Reactivity Human
Specificity This kit recognizes Human AGER in samples.No significant cross-reactivity or interference between Human AGER and analogues was observed
Recovery 80%-120%
Sample Type Serum, plasma and other biological fluids
Detection Method Chemiluminescence
Assay Type Sandwich-CLIA
Size 96T / 48T / 24T / 96T*5 / 96T*10
Storage 2-8℃/-20℃
Expiration Date 6 months
Typical data
The following data was generated by the Quality Control Department, under controlled laboratory conditions (ambient temperature: 18-25 °C, relative humidity: 35-75%) using standardized procedures (TMB reaction at 37 °C in the dark for 15 minutes, followed by termination and OD measurement). These values are provided for reference only. Actual results may vary due to differences in laboratory conditions, operator technique, and equipment. Users are required to generate a standard curve using their own experimental data.
pg/mL OD1 OD2 Mean OD Corrected OD
1000 54472.000 59778.000 57125.000 57088
500 22600.000 24852.000 23726.000 23689
250 11144.000 10860.000 11002.000 10965
125 5179.000 5411.000 5295.000 5258
62.5 2803.000 2521.000 2662.000 2625
31.25 1438.000 1338.000 1388.000 1351
15.63 760.000 794.000 777.000 740
0 36.000 38.000 37.000 -
Precision
Intra-assay Precision (Within-run Precision): Three samples representing low, mid, and high concentrations of Human IL-6 were tested 20 times on a single plate.
Inter-assay Precision (Between-run Precision): Three samples representing low, mid, and high concentrations of Human IL-6 were tested on three separate plates, with 20 replicates per plate, to assess variability among assays.
/ Intra-assay Precision Inter-assay Precision
Sample 1 2 3 1 2 3
Numbers 20 20 20 20 20 20
Mean(pg/mL) 51.110 157.180 401.390 46.720 155.270 398.690
Standard deviation 6.010 11.320 26.890 5.800 18.480 31.460
CV(%) 11.760 7.200 6.700 12.410 11.900 7.890
Recovery
The recovery of Human AGER was evaluated by spiking samples at low, mid, and high concentrations across the assay range in various sample matrices.
The assay performance was assessed by comparing the measured concentrations to the expected spiked amounts to determine the percent recovery.
Sample Type Range (%) Average Recovery(%)
Serum (n=8) 85-97 91
EDTA plasma (n=8) 97-109 104
Cell culture media (n=8) 99-115 106
Linearity
Linearity of the assay was evaluated by spiking samples with high concentrations of Human AGER and performing serial dilutions using Standard & Sample Diluent to produce concentrations spanning the assay's dynamic range. The measured values were then compared to the expected concentrations to assess the linearity of response.
/ / Cell culture media
(n=5)
EDTA plasma
(n=5)
Serum
(n=5)
1:2 Range 92-106 101-114 100-113
Average 98 108 106
1:4 Range 103-116 91-104 94-106
Average 109 97 100
1:8 Range 91-104 99-114 100-116
Average 98 107 109
This CLIA kit uses the Sandwich-CLIA principle. The micro CLIA plate provided in this kit has been pre-coated with an antibody specific to Human AGER. Samples or Standards are added to the micro CLIA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human AGER and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human AGER, biotinylated detection antibody and Avidin-HRP conjugate will appear luminescence. The Relative light unit (RLU) value is measured by the Chemiluminescence immunoassay analyzer at 425nm. The RLU value is positively associated with the concentration of Human AGER. You can calculate the concentration of Human AGER in the samples by comparing the RLU value of the samples to the standard curve.
Gene ID 177
Uniport ID Q15109
Research Area Cancer , Cardiovascular , Neuroscience
Human AGER (Total Advanced Glycosylation End Product Specific Receptor) CLIA Kit - procedures
  • IF:{{item.impact}}

    Journal:{{item.journal}} ({{item.year}})

    DOI:{{item.doi}}

    Reactivity:{{item.species}}

    Sample Type:{{item.sample_type}}

  • Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}

No files available. Please enter the correct identification code in the search area to query the relevant documents.

empty
Product Information
Title Status Valid until Action
{{v.文件名}} {{v.status_str}} {{v.timestamp_str}} Download /

*Note:Please download the relevant files within the validity period. After expiration, file preview and download will not be available on the page.

确定